The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of fruquintinib in the first- (1L) or second-line (2L) treatment of unresectable metastatic soft tissue sarcoma.
 
Zhiguo Luo
No Relationships to Disclose
 
Xiaowei Zhang
No Relationships to Disclose
 
Ting Zhao
No Relationships to Disclose
 
Bi-Qiang Zheng
No Relationships to Disclose
 
Wangjun Yan
No Relationships to Disclose
 
Yong Chen
No Relationships to Disclose
 
Yu Xu
No Relationships to Disclose
 
Chun-Meng Wang
No Relationships to Disclose
 
Junhua Zhang
No Relationships to Disclose
 
Jian Wang
No Relationships to Disclose
 
Lin Yu
No Relationships to Disclose
 
Xin Liu
No Relationships to Disclose